Emerging Gene Therapies and Targeted Agents for Patients with Hemophilia

	Emerging Gene Therapies and Targeted Agents for Patients with Hemophilia CME, CPE Steven W. Pipe, MD
	Release Date: July 29, 2022 Expiration Date: July 29, 2023
	Join Dr. Pipe as he outlines new innovations and findings relative to hemophilia A and B. Topics include gene therapy, anti-tissue factor pathway inhibitors, and other exciting developments in hemophilia. Provided by MediCom Worldwide, Inc. This activity is supported by an educational grant from CSL Behring, LLC.
	Begin, Earn Credit View Only, No Credit